Back to Search
MIRIAM MICHAEL, MD
MD
Internal Medicine Physician
NPI: 1477565059IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D52299(MD)MD30512(DC)
Nephrology Physician
Internal Medicine — Nephrology
Code: 207RN0300X
MD30512(DC)
Hospitalist Physician
Hospitalist
Code: 208M00000X
D52299(MD)
Education
HOWARD UNIVERSITY COLLEGE OF MEDICINE
Class of 1992
Research & Publications (20)
Panayiotopoulos syndrome: an important childhood autonomic epilepsy to be differentiated from occipital epilepsy and acute non-epileptic disorders.
PMID 19386455·Brain Dev·2010
6-review
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
PMID 19242371·J Immunother·2009
8-other
Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection.
PMID 19337695·J Neurooncol·2009
7-preclinical
Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
PMID 18950913·Am J Kidney Dis·2009
1-meta
Role of xenobiotic metabolic enzymes in cancer epidemiology.
PMID 19107436·Methods Mol Biol·2009
6-review
MicroRNA-143 and -205 expression in neosquamous esophageal epithelium following Argon plasma ablation of Barrett's esophagus.
PMID 19190970·J Gastrointest Surg·2009
2-rct
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation.
PMID 19492298·Stem Cells·2009
8-other
Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
PMID 19470704·Endocrinology·2009
7-preclinical
Use of stabilizing mutations to engineer a charged group within a ligand-binding hydrophobic cavity in T4 lysozyme.
PMID 19663503·Biochemistry·2009
8-other
Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer.
PMID 19672255·Br J Cancer·2009
8-other
A pilot human evaluation of a formulation of irinotecan and hyaluronic acid in 5-fluorouracil-refractory metastatic colorectal cancer patients.
PMID 19060478·Chemotherapy·2009
3-trial
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.
PMID 19088724·Br J Cancer·2009
3-trial
Reversible parkinsonism due to chronic bilateral subdural hematomas.
PMID 19138853·J Clin Neurosci·2009
5-case
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.
PMID 19160220·Cochrane Database Syst Rev·2009
1-meta
Prostate-specific antigen in the cerebrospinal fluid: a marker of local disease.
PMID 18830829·Med Oncol·2009
5-case
Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.
PMID 19294559·Leuk Lymphoma·2009
8-other
Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer.
PMID 19002384·Invest New Drugs·2009
3-trial
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study.
PMID 19406901·Ann Oncol·2009
3-trial
Responses on a lateralized lexical decision task relate to both reading times and comprehension.
PMID 19559514·Brain Cogn·2009
8-other
Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer.
PMID 19250769·Int J Radiat Oncol Biol Phys·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 827 LINDEN AVE
BALTIMORE, MD 21201 - Phone
- (410) 225-8790
Quick Facts
- NPI
- 1477565059
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 34
- Publications
- 20
Are you this provider?
Claim Your Profile